Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational Study
暂无分享,去创建一个
Thomas Lehmann | Andreas Michalsen | Nico Steckhan | A. Michalsen | T. Lehmann | F. Wilhelmi de Toledo | F. Grundler | S. Drinda | T. Neumann | Stefan Drinda | Franziska Grundler | Thomas Neumann | Francoise Wilhelmi de Toledo | N. Steckhan
[1] E. Jackvony,et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.
[2] Roy Taylor,et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial , 2017, The Lancet.
[3] P. Kerndt,et al. Fasting: the history, pathophysiology and complications. , 1982, The Western journal of medicine.
[4] A. Michalsen,et al. Effects of A One-week Fasting Therapy in Patients with Type-2 Diabetes Mellitus and Metabolic Syndrome – A Randomized Controlled Explorative Study , 2017, Experimental and Clinical Endocrinology & Diabetes.
[5] S. Moebus,et al. Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. , 2005, Journal of alternative and complementary medicine.
[6] S. Burgess,et al. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. , 2011, The American journal of clinical nutrition.
[7] A. Stein,et al. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. , 2018, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[8] A. Michalsen,et al. Fasting Therapy for Treating and Preventing Disease - Current State of Evidence , 2013, Complementary Medicine Research.
[9] Vincent Wai-Sun Wong,et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years , 2010, Gut.
[10] J. George,et al. The role of diet and nutritional intervention for the management of patients with NAFLD. , 2014, Clinics in liver disease.
[11] S. Friedman,et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. , 2015, Gastroenterology.
[12] Benjamin S. Aribisala,et al. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. , 2018, Cell metabolism.
[13] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[14] A. Baranova,et al. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.
[15] Anna Castiglione,et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.
[16] Feng Li,et al. Weight reduction for non-alcoholic fatty liver disease. , 2011, The Cochrane database of systematic reviews.
[17] A. Roverato,et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis , 2016, Journal of gastroenterology and hepatology.
[18] R. Schwenk,et al. Caloric restriction and intermittent fasting alter hepatic lipid droplet proteome and diacylglycerol species and prevent diabetes in NZO mice. , 2015, Biochimica et biophysica acta.
[19] A. Suzuki,et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease , 2010, Hepatology.
[20] A. Michalsen,et al. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects , 2019, PloS one.
[21] A. Moschetta,et al. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 , 2015, Nature Reviews Drug Discovery.
[22] T. Elhadd,et al. Differential effects of gender and patient background diversity on the changes in metabolic and biophysical profiles in people with type-2 diabetes from different ethnicities who fast during Ramadan (H1439); a prospective study from Qatar. , 2019, Diabetes research and clinical practice.
[23] V. Wong,et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. , 2018, Journal of hepatology.
[24] Magnolia Cardona-Morrell,et al. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis , 2010, BMC public health.
[25] S. Shin,et al. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. , 2014, New England Journal of Medicine.
[26] R. Tayyem,et al. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. , 2018, Diabetes & metabolic syndrome.
[27] Y. Rotman,et al. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease , 2016, Gut.
[28] A. Michalsen,et al. Fasting Therapy - an Expert Panel Update of the 2002 Consensus Guidelines , 2013, Complementary Medicine Research.
[29] P. Puchalska,et al. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. , 2017, Cell metabolism.
[30] K. Khunti,et al. Diabetes Prevention in the Real World: Effectiveness of Pragmatic Lifestyle Interventions for the Prevention of Type 2 Diabetes and of the Impact of Adherence to Guideline Recommendations , 2014, Diabetes Care.
[31] C. Day,et al. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance , 2016, British Medical Journal.
[32] L. Adams,et al. International Journal of Molecular Sciences the Natural Course of Non-alcoholic Fatty Liver Disease , 2022 .
[33] Xuchen Zhang,et al. Non-alcoholic fatty liver disease: An expanded review , 2017, World journal of hepatology.
[34] K. Faber,et al. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort , 2017, PloS one.
[35] George F Cahill,et al. Fuel metabolism in starvation. , 2006, Annual review of nutrition.
[36] Amalia Gastaldelli,et al. Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance , 2014, PloS one.
[37] Benjamin S. Aribisala,et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol , 2011, Diabetologia.
[38] F. Schick,et al. The impact of liver fat vs visceral fat in determining categories of prediabetes , 2010, Diabetologia.
[39] S. O. Lima,et al. Association of the Nonalcoholic Hepatic Steatosis and Its Degrees With the Values of Liver Enzymes and Homeostasis Model Assessment-Insulin Resistance Index , 2015, Gastroenterology research.
[40] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[41] G. Shulman. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. , 2014, The New England journal of medicine.
[42] Michael Charlton,et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.
[43] G. Marchesini,et al. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[44] M. Laakso,et al. Ketone body production is differentially altered in steatosis and non‐alcoholic steatohepatitis in obese humans , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[45] J. Krakauer,et al. The association between a body shape index and cardiovascular risk in overweight and obese children and adolescents , 2018, PloS one.